Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

Neuro-oncology scientists discover unique molecular mechanism that maintains glioma stem cells

Neuro-oncology scientists discover unique molecular mechanism that maintains glioma stem cells

Diagnosing prostate cancer through a £225 urine test

Diagnosing prostate cancer through a £225 urine test

Ground-breaking new breast cancer drugs have manageable toxicity profile for most patients

Ground-breaking new breast cancer drugs have manageable toxicity profile for most patients

ASTRO releases updated insurance coverage recommendations for proton beam therapy to treat cancer

ASTRO releases updated insurance coverage recommendations for proton beam therapy to treat cancer

Tall and obese men at increased risk of aggressive prostate cancer, study finds

Tall and obese men at increased risk of aggressive prostate cancer, study finds

Surgery may not prolong life in men with early-stage prostate cancer

Surgery may not prolong life in men with early-stage prostate cancer

Neolys Diagnostics announces new precise, rapid blood test to evade radiotherapy side effects

Neolys Diagnostics announces new precise, rapid blood test to evade radiotherapy side effects

Scientists reveal role of cellular prion protein in development of NF2-related tumors

Scientists reveal role of cellular prion protein in development of NF2-related tumors

Cancer death rates in rural America slower to decline compared to urban areas

Cancer death rates in rural America slower to decline compared to urban areas

New molecular technique can clone thousands of long DNA sequences at the same time

New molecular technique can clone thousands of long DNA sequences at the same time

Differential RNA splicing may play role in prostate cancer disparities in African-American men

Differential RNA splicing may play role in prostate cancer disparities in African-American men

Novel micro-cubes can efficiently deliver hydrophobic anti-tumor drug to cancer cells

Novel micro-cubes can efficiently deliver hydrophobic anti-tumor drug to cancer cells

Researchers suggest new strategy to identify germline mutations in men with prostate cancer

Researchers suggest new strategy to identify germline mutations in men with prostate cancer

American scientists develop bioorthogonal labeling test to assess sialylated glycans in tumor cells

American scientists develop bioorthogonal labeling test to assess sialylated glycans in tumor cells

Tiny biological nanoparticles offer enormous potential for diagnostic and therapeutic applications

Tiny biological nanoparticles offer enormous potential for diagnostic and therapeutic applications

Could a blood test predict how cancer spreads in children?

Could a blood test predict how cancer spreads in children?

Scientists develop new three-in-one blood test that could transform prostate cancer treatment

Scientists develop new three-in-one blood test that could transform prostate cancer treatment

Expert suggests tips for families to help dad take care of his health

Expert suggests tips for families to help dad take care of his health

New biosensor technology could be used in wearable devices to monitor health

New biosensor technology could be used in wearable devices to monitor health

Researchers pinpoint sugar modification in cells that spurs spread of skin cancer

Researchers pinpoint sugar modification in cells that spurs spread of skin cancer